Cinctive Capital Management LP Sells 46,629 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cinctive Capital Management LP lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 41.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 64,828 shares of the medical instruments supplier's stock after selling 46,629 shares during the period. Cinctive Capital Management LP's holdings in DENTSPLY SIRONA were worth $1,754,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of the business. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock worth $25,000 after buying an additional 753 shares in the last quarter. Capital Performance Advisors LLP bought a new position in DENTSPLY SIRONA in the third quarter worth approximately $27,000. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after purchasing an additional 564 shares in the last quarter. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA in the second quarter valued at approximately $32,000. Finally, Kennebec Savings Bank bought a new position in shares of DENTSPLY SIRONA in the third quarter valued at approximately $35,000. Institutional investors own 95.70% of the company's stock.

Analysts Set New Price Targets

XRAY has been the subject of a number of recent research reports. Barrington Research decreased their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, November 8th. Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research note on Wednesday. They issued a "neutral" rating and a $21.00 price target for the company. Leerink Partners downgraded shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average target price of $28.40.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.07 during trading on Wednesday, reaching $19.46. The company had a trading volume of 2,022,343 shares, compared to its average volume of 3,109,484. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market capitalization of $3.87 billion, a PE ratio of -9.40, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. The firm's fifty day moving average is $22.17 and its 200 day moving average is $24.59.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million for the quarter, compared to analysts' expectations of $939.10 million. During the same period in the prior year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA's revenue was up .4% compared to the same quarter last year. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.